Exane Derivatives’s Twenty-First Century Fox, Inc. Class A TFCFA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-1
Closed -$46 759
2018
Q3
$46 Sell
1
-45
-98% -$2.06K ﹤0.01% 645
2018
Q2
$2.29K Sell
46
-229
-83% -$9.05K ﹤0.01% 490
2018
Q1
$9.98K Sell
275
-882
-76% -$32.6K ﹤0.01% 416
2017
Q4
$39.9K Sell
1,157
-9,054
-89% -$270K 0.01% 360
2017
Q3
$269K Buy
10,211
+220
+2% +$6.06K 0.05% 183
2017
Q2
$283K Buy
+9,991
New +$287K 0.06% 181
2016
Q2
Sell
-7
Closed -$195 643
2016
Q1
$195 Sell
7
-4,374
-100% -$117K ﹤0.01% 502
2015
Q4
$119K Sell
4,381
-2,751
-39% -$79.8K 0.02% 188
2015
Q3
$192K Buy
7,132
+6,132
+613% +$183K 0.02% 190
2015
Q2
$32.5K Buy
+1,000
New +$33.6K ﹤0.01% 314

Other funds holding TFCFA

Exane Derivatives's TFCFA Position: Q4 2018 in Review

Exane Derivatives sold out of Twenty-First Century Fox, Inc. Class A (TFCFA) in Q4 2018, closing a stake of 1 share — an estimated $46 sold.

Exane Derivatives first reported a position in TFCFA in Q2 2015 and held it in 10 quarters. The position peaked at $283K in Q2 2017. 708 funds tracked by Wall St. Rank hold TFCFA as of Q4 2018.

  • Exane Derivatives reported no remaining Twenty-First Century Fox, Inc. Class A position as of Q4 2018 after selling out during the quarter.
  • Exane Derivatives sold 1 Twenty-First Century Fox, Inc. Class A share in Q4 2018, an estimated $46.
  • Exane Derivatives first reported a position in Twenty-First Century Fox, Inc. Class A in Q2 2015 and held it in 10 quarters.
  • Exane Derivatives's Twenty-First Century Fox, Inc. Class A position peaked at $283K in Q2 2017.
  • 708 funds tracked by Wall St. Rank held Twenty-First Century Fox, Inc. Class A as of Q4 2018.

Based on Exane Derivatives's 13F filing for Q4 2018, filed 31 Jan 2019.